About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) has been publicly traded since 1995, making it a 31-year-old public company. It operates in the Medical Distribution industry within the Healthcare sector. The company is headquartered in Melville, United States and employs approximately 25,000 people. With a market capitalization of $8.9 billion, HSIC is a mid-sized company with growth potential.
Key Statistics
- Current Price
- $75.57
- Market Cap
- $8.90B
- 52-Week High
- $89.29
- 52-Week Low
- $60.56
- Sector
- Healthcare
- Industry
- Medical Distribution
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -0.01% | $75.58 | $75.57 |
| 2025 | +9.22% | $69.20 | $75.58 |
| 2024 | -8.60% | $75.71 | $69.20 |
| 2023 | -5.21% | $79.87 | $75.71 |
| 2022 | +3.02% | $77.53 | $79.87 |
| 2021 | +15.96% | $66.86 | $77.53 |
| 2020 | +0.21% | $66.72 | $66.86 |
| 2019 | +8.34% | $61.58 | $66.72 |
| 2018 | +12.36% | $54.81 | $61.58 |
| 2017 | -7.88% | $59.49 | $54.81 |
| 2016 | -4.10% | $62.04 | $59.49 |
| 2015 | +16.19% | $53.39 | $62.04 |
| 2014 | +19.16% | $44.81 | $53.39 |
| 2013 | +42.08% | $31.54 | $44.81 |
| 2012 | +24.82% | $25.27 | $31.54 |
| 2011 | +4.95% | $24.07 | $25.27 |
| 2010 | +16.71% | $20.63 | $24.07 |
| 2009 | +43.36% | $14.39 | $20.63 |
| 2008 | -40.24% | $24.08 | $14.39 |
| 2007 | +25.36% | $19.21 | $24.08 |
| 2006 | +12.24% | $17.11 | $19.21 |
| 2005 | +25.33% | $13.65 | $17.11 |
| 2004 | +3.05% | $13.25 | $13.65 |
| 2003 | +50.18% | $8.82 | $13.25 |
| 2002 | +21.52% | $7.26 | $8.82 |
| 2001 | +6.95% | $6.79 | $7.26 |
| 2000 | +160.09% | $2.61 | $6.79 |
| 1999 | -70.25% | $8.77 | $2.61 |
| 1998 | +27.86% | $6.86 | $8.77 |
| 1997 | +1.82% | $6.74 | $6.86 |
| 1996 | +16.53% | $5.78 | $6.74 |
Valuation
HSIC currently trades at a trailing P/E ratio of 23.1, which is considered moderate relative to the broader market. The forward P/E of 12.8 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 2.7. The price-to-sales ratio is 0.7.
Dividends
Henry Schein, Inc. does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
HSIC has a beta of 0.85, indicating it is similarly volatile to the overall market. The stock's 52-week range is $60.56 to $89.29, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 14 analyst opinions, HSIC has a consensus "buy" rating. The average price target of $89.79 suggests 18.8% upside from current levels.
Frequently Asked Questions
What does Henry Schein, Inc. do? ▼
Henry Schein, Inc. is a Medical Distribution company operating in the Healthcare sector. The company is headquartered in Melville, United States.
What sector is HSIC in? ▼
HSIC operates in the Healthcare sector, specifically in the Medical Distribution industry.
When did HSIC go public? ▼
Henry Schein, Inc. went public in 1995, making it a 31-year-old public company as of 2026.
How much would $1,000 invested in HSIC 5 years ago be worth today? ▼
A $1,000 investment in HSIC five years ago would be worth approximately $1,159 today, representing a 15.9% return.
Does HSIC pay dividends? ▼
No, Henry Schein, Inc. does not currently pay a dividend. The company reinvests its earnings into growth.
What is HSIC's market cap? ▼
Henry Schein, Inc. has a market capitalization of $8.9 billion, classifying it as a mid-cap company.
What is HSIC's P/E ratio? ▼
HSIC has a trailing P/E ratio of 23.1 and a forward P/E of 12.8, which measures how much investors are paying per dollar of earnings.
Is HSIC a buy, hold, or sell? ▼
Based on 14 opinions, HSIC has a consensus "buy" rating. The average price target is $89.79.
Last updated: 3/14/2026